Neurons Derived From Patient-Specific Induced Pluripotent Stem Cells: a Promising Strategy Towards Developing Novel Pharmacotherapies for Autism Spectrum Disorders
Main Authors: | Ryan Mokhtari, Herbert M. Lachman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-07-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396416302900 |
Similar Items
-
Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease Drug Development
by: S. A. Antonov, et al.
Published: (2021-03-01) -
Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome
by: Hélène Darville, et al.
Published: (2016-07-01) -
Characterization of Induced Pluripotent Stem Cell-derived Human Serotonergic Neurons
by: Lining Cao, et al.
Published: (2017-05-01) -
Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells
by: Iya Prytkova, et al.
Published: (2017-11-01) -
Comparative Neuronal Differentiation of Self-Renewing Neural Progenitor Cell Lines Obtained from Human Induced Pluripotent Stem Cells
by: Chiara eVerpelli, et al.
Published: (2013-10-01)